Sencure Secures €7.9M to Revolutionize Wearable Health Tech
Summary
Its total fundingincluding non-dilutive sourcesamounts to over 15 million in the last 4 years.At the heart of Sencures success is its flagship product, the SNCE800 IC a high-performance, low-power chip thats setting new standards for wearable medical devices. The SNCE800 is poised to power a new generation of wearable health products, from EEG-enabled earbuds and headbands to ECG patches and EMG-based wearables.As the global demand for compact, efficient medical devices surgesdriven by an aging population and rapid healthcare digitalizationSencures innovations are leading the charge in creating smarter, more efficient solutions.With investment backing from Cottonwood Technology Fund, Bluegrass Ventures, NV NOM, and 819 Capital Partners, Sencure is gearing up for a major expansion. We are thrilled to welcome Bluegrass Ventures to our family of investors and to strengthen our existing partnerships, said Sencure CEO Dick van Waes. Their approach to healthcare solutions is visionary, and I look forward to being part of their journey.Additionally, the companys newly appointed VP of R&D, William Trilsbeek, will spearhead efforts in Nijmegen. As the company continues its mission to miniaturize and enhance medical wearables, the future looks brighter than ever.We invested in Sencure through 819 Evergreen Fund.